Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth M Steinberg

Showing results (331-340 of 481) with videos related to

Pageof 49
Sort By:
Frontiers in Oncology|March 22, 2021
Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced Stage Breast CancerMargaret E Gatti-Mays, Sofia R Gameiro, Yohei Ozawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2021
Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALLNirali N Shah, Daniel W Lee, Bonnie Yates, et al.
BJU International|February 20, 2013
Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancerWilliam L Dahut, Ravi A Madan, Joyson J Karakunnel, et al.
Nature Medicine|August 24, 2005
Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphomaSattva S Neelapu, Larry W Kwak, Carol B Kobrin, et al.
Rheumatology (Oxford, England)|December 7, 2021
Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosusSencer Goklemez, Sarfaraz Hasni, Frances T Hakim, et al.
Blood Advances|October 7, 2021
Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 daysLekha Mikkilineni, Bonnie Yates, Seth M Steinberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2015
Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host diseaseKristin Baird, Leora E Comis, Galen O Joe, et al.
Cancer Biology & Therapy|September 3, 2005
A phase II study of perifosine in androgen independent prostate cancerEdwin M Posadas, James Gulley, Philip M Arlen, et al.
Clinical Colorectal Cancer|July 29, 2019
A Pilot Study of the PD-1 Targeting Agent AMP-224 Used With Low-Dose Cyclophosphamide and Stereotactic Body Radiation Therapy in Patients With Metastatic Colorectal CancerCharalampos S Floudas, Gagandeep Brar, Donna Mabry-Hrones, et al.
Trials|December 25, 2009
The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy aloneSid P Kerkar, Clinton D Kemp, Austin Duffy, et al.
Pageof 49

Showing results (331-340 of 481) with videos related to

Sort By:
Pageof 49
Frontiers in Oncology|March 22, 2021
Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced Stage Breast CancerMargaret E Gatti-Mays, Sofia R Gameiro, Yohei Ozawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2021
Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALLNirali N Shah, Daniel W Lee, Bonnie Yates, et al.
BJU International|February 20, 2013
Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancerWilliam L Dahut, Ravi A Madan, Joyson J Karakunnel, et al.
Nature Medicine|August 24, 2005
Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphomaSattva S Neelapu, Larry W Kwak, Carol B Kobrin, et al.
Rheumatology (Oxford, England)|December 7, 2021
Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosusSencer Goklemez, Sarfaraz Hasni, Frances T Hakim, et al.
Blood Advances|October 7, 2021
Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 daysLekha Mikkilineni, Bonnie Yates, Seth M Steinberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2015
Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host diseaseKristin Baird, Leora E Comis, Galen O Joe, et al.
Cancer Biology & Therapy|September 3, 2005
A phase II study of perifosine in androgen independent prostate cancerEdwin M Posadas, James Gulley, Philip M Arlen, et al.
Clinical Colorectal Cancer|July 29, 2019
A Pilot Study of the PD-1 Targeting Agent AMP-224 Used With Low-Dose Cyclophosphamide and Stereotactic Body Radiation Therapy in Patients With Metastatic Colorectal CancerCharalampos S Floudas, Gagandeep Brar, Donna Mabry-Hrones, et al.
Trials|December 25, 2009
The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy aloneSid P Kerkar, Clinton D Kemp, Austin Duffy, et al.
Pageof 49